| Ytd | 18.21% | |
| 1y | 65.51% |
| Open | 52.12 | Prev Close | 51.89 | Low | 51.25 | High | 53.13 | Mkt Cap | 6.24B |
| Vol | 0.00 | Avg Vol | 1.38M | EPS | -3.45 | P/E | -15.09 | Forward P/E | -22.81 |
| Beta | 0.67 | Short Ratio | 9.81 | Inst. Own | 118.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 50.04 | 200-d Avg | 45.29 | 1yr Est | 59.94 |
SRRK News
Scholar Rock shifts its FDA review for SMA treatment apitegromab to a secondary facility, keeping th
Scholar Rock said on Friday it would remove Catalent's Indiana manufacturing facility from its appli
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company d
Scholar Rock NASDAQ: SRRK said its resubmitted biologics license application for apitegromab remains
Scholar Rock Holding Corporation (SRRK) Q2 2026 Earnings Call Transcript
Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company d
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company d
Kuehn Law Encourages Investors of Scholar Rock Holding Corp to Contact Law Firm PR Newswire NEW YORK
NEW YORK, July 28, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inves
Wedbush analyst David Nierengarten reiterates Scholar Rock Holding (NASDAQ:SRRK) with a Outperfor
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i
Scholar Rock said on Monday a European Union opinion on its experimental spinal muscular atrophy tre
Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company d
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that t
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK) today announced that it will report s
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company d
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that t
Scholar Rock Holding Corporation (SRRK) Presents at Goldman Sachs 47th Annual Global Healthcare Conf
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company d
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company d
Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to talk about, and the reaso
Top Wall Street analysts changed their outlook on top names. For a complete view of all rating chang
US stocks rise, Dow Jones gains 600+ pts. Apellis Pharma shares surge 136.4% after buyout by Biogen
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Gainers
On Monday, 198 companies reached new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Wednesday's session saw 784 companies set new 52-week lows.
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week
On Friday, 431 companies hit new 52-week lows.
On Monday, 671 companies achieved new lows for the year.
During Friday's session, 445 companies made new 52-week lows.
Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the c
This morning 279 companies reached new 52-week highs.